Polaris Genomics
PrivateLast Round
Debt
Sep 3, 2025
Total Funding Raised
$5.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Polaris Genomics is a biotechnology company that develops AI-powered genomic diagnostics and therapeutics for mental health and neuropsychiatric conditions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Mental Health, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polaris Genomics Comparables
Compare Polaris Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivid Genomics | 81% | |
| Circular Genomics | 78% | |
| MindX Sciences | 78% | |
Polaris Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 3, 2025 | ||||
| Seed | Nov 1, 2023 | ||||
| Grant | Nov 2, 2022 | ||||
| Grant | Sep 20, 2022 | ||||
| Grant | Jul 19, 2022 | ||||
Grant | Jan 5, 2022 |
Key People
Founding team and executive leadership
Polaris Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Seed |
| Wavemaker Three-Sixty Health | Seed |
| Maryland Industrial Partnerships (MIPS) | Grant |
| Viking Global Investors | Seed |
| AFVentures | Grant |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors increased 87% MoM.
- Sep 3, 2025
$250K debt round completed.
Polaris Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Polaris Genomics's valuation, stock price, and market status.